Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 193

1.

Human monoclonal HLA antibodies reveal interspecies crossreactive swine MHC class I epitopes relevant for xenotransplantation.

Mulder A, Kardol MJ, Arn JS, Eijsink C, Franke ME, Schreuder GM, Haasnoot GW, Doxiadis II, Sachs DH, Smith DM, Claas FH.

Mol Immunol. 2010 Jan;47(4):809-15. doi: 10.1016/j.molimm.2009.10.004. Epub 2009 Nov 22.

PMID:
19931911
2.

Phenotypic variance in childhood coeliac disease and the HLA-DQ/DR dose effect.

Vermeulen BA, Hogen Esch CE, Yuksel Z, Koning F, Verduijn W, Doxiadis II, Schreuder GM, Mearin ML.

Scand J Gastroenterol. 2009;44(1):40-5. doi: 10.1080/00365520802116422.

PMID:
18932050
3.

Progression of joint damage in early rheumatoid arthritis: association with HLA-DRB1, rheumatoid factor, and anti-citrullinated protein antibodies in relation to different treatment strategies.

de Vries-Bouwstra JK, Goekoop-Ruiterman YP, Verpoort KN, Schreuder GM, Ewals JA, Terwiel JP, Ronday HK, Kerstens PJ, Toes RE, de Vries RR, Breedveld FC, Dijkmans BA, Huizinga TW, Allaart CF.

Arthritis Rheum. 2008 May;58(5):1293-8. doi: 10.1002/art.23439.

4.

The relationship between HLA class II polymorphisms and somatic deletions in testicular B cell lymphomas of Dutch patients.

Riemersma SA, Jordanova ES, Haasnoot GW, Drabbels J, Schuuring E, Schreuder GM, Kluin PM.

Hum Immunol. 2006 Apr-May;67(4-5):303-10. Epub 2006 Apr 7.

PMID:
16720210
5.

HLA Class I and II genotype in uveal melanoma: relation to occurrence and prognosis.

Maat W, Haasnoot GW, Claas FH, Schalij-Delfos NE, Schreuder GM, Jager MJ.

Invest Ophthalmol Vis Sci. 2006 Jan;47(1):3-6.

PMID:
16384937
6.

Refining the complex rheumatoid arthritis phenotype based on specificity of the HLA-DRB1 shared epitope for antibodies to citrullinated proteins.

Huizinga TW, Amos CI, van der Helm-van Mil AH, Chen W, van Gaalen FA, Jawaheer D, Schreuder GM, Wener M, Breedveld FC, Ahmad N, Lum RF, de Vries RR, Gregersen PK, Toes RE, Criswell LA.

Arthritis Rheum. 2005 Nov;52(11):3433-8.

7.

Association of HLA-DR3 with anti-cyclic citrullinated peptide antibody-negative rheumatoid arthritis.

Verpoort KN, van Gaalen FA, van der Helm-van Mil AH, Schreuder GM, Breedveld FC, Huizinga TW, de Vries RR, Toes RE.

Arthritis Rheum. 2005 Oct;52(10):3058-62.

8.

An independent role of protective HLA class II alleles in rheumatoid arthritis severity and susceptibility.

van der Helm-van Mil AH, Huizinga TW, Schreuder GM, Breedveld FC, de Vries RR, Toes RE.

Arthritis Rheum. 2005 Sep;52(9):2637-44.

9.

Nomenclature for Factors of the HLA System, 2004.

Marsh SG, Albert ED, Bodmer WF, Bontrop RE, Dupont B, Erlich HA, Geraghty DE, Hansen JA, Hurley CK, Mach B, Mayr WR, Parham P, Petersdorf EW, Sasazuki T, Schreuder GM, Strominger JL, Svejgaard A, Terasaki PI, Trowsdale J.

Hum Immunol. 2005 May;66(5):571-636. Epub 2005 Mar 3. No abstract available.

PMID:
15935895
10.

Nomenclature for factors of the HLA system, 2004.

Marsh SG, Albert ED, Bodmer WF, Bontrop RE, Dupont B, Erlich HA, Geraghty DE, Hansen JA, Hurley CK, Mach B, Mayr WR, Parham P, Petersdorf EW, Sasazuki T, Schreuder GM, Strominger JL, Svejgaard A, Terasaki PI, Trowsdale J.

Tissue Antigens. 2005 Apr;65(4):301-69. No abstract available.

PMID:
15787720
11.

Nomenclature for factors of the HLA system, 2004.

Marsh SG, Albert ED, Bodmer WF, Bontrop RE, Dupont B, Erlich HA, Geraghty DE, Hansen JA, Hurley CK, Mach B, Mayr WR, Parham P, Petersdorf EW, Sasazuki T, Schreuder GM, Strominger JL, Svejgaard A, Terasaki PI, Trowsdale J.

Int J Immunogenet. 2005 Apr;32(2):107-59. No abstract available.

PMID:
15787643
12.

HLA dictionary 2004: summary of HLA-A, -B, -C, -DRB1/3/4/5, -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR, and -DQ antigens.

Schreuder GM, Hurley CK, Marsh SG, Lau M, Fernandez-Vina MA, Noreen HJ, Setterholm M, Maiers M.

Hum Immunol. 2005 Feb;66(2):170-210.

PMID:
15695003
13.

The HLA Dictionary 2004: a summary of HLA-A, -B, -C, -DRB1/3/4/5 and -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR and -DQ antigens.

Schreuder GM, Hurley CK, Marsh SG, Lau M, Fernandez-Vina M, Noreen HJ, Setterholm M, Maiers M.

Int J Immunogenet. 2005 Feb;32(1):19-69.

PMID:
15686589
14.

The HLA Dictionary 2004: a summary of HLA-A, -B, -C, -DRB1/3/4/5 and -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR and -DQ antigens.

Schreuder GM, Hurley CK, Marsh SG, Lau M, Fernandez-Vina M, Noreen HJ, Setterholm M, Maiers M; World Marrow Donor Associations Quality Assurance and IT Working Groups; WHO Nomenclature Committee for Factors of the HLA system; 13th International Histocompatibility Workshop Serology Component; International Cell Exchange, UCLA; US National Marrow Donor Program.

Tissue Antigens. 2005 Jan;65(1):1-55. Review.

PMID:
15663741
15.

HLA class II alleles are not a general susceptibility factor in Guillain-Barré syndrome.

Geleijns K, Schreuder GM, Jacobs BC, Sintnicolaas K, van Koningsveld R, Meulstee J, Laman JD, van Doorn PA.

Neurology. 2005 Jan 11;64(1):44-9.

PMID:
15642902
16.

Associations with autoimmune disorders and HLA class I and II antigens in inclusion body myositis.

Badrising UA, Schreuder GM, Giphart MJ, Geleijns K, Verschuuren JJ, Wintzen AR, Maat-Schieman ML, van Doorn P, van Engelen BG, Faber CG, Hoogendijk JE, de Jager AE, Koehler PJ, de Visser M, van Duinen SG; Dutch IBM Study Group.

Neurology. 2004 Dec 28;63(12):2396-8.

PMID:
15623710
17.

Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis.

van Gaalen FA, van Aken J, Huizinga TW, Schreuder GM, Breedveld FC, Zanelli E, van Venrooij WJ, Verweij CL, Toes RE, de Vries RR.

Arthritis Rheum. 2004 Jul;50(7):2113-21.

18.

Difference in pathogenesis between vitiligo vulgaris and halo nevi associated with vitiligo is supported by an HLA association study.

de Vijlder HC, Westerhof W, Schreuder GM, de Lange P, Claas FH.

Pigment Cell Res. 2004 Jun;17(3):270-4.

PMID:
15140072
19.

Five newly identified HLA alleles: A*0310, A*2907, B*4435, Cw*0206, Cw*0506, and confirmation of A*3106, B*3924, Cw*0314, DRB1*0322, and DRB1*1433 alleles.

Anholts JD, Drabbels J, Verduijn W, Oudshoorn M, Schreuder GM.

Tissue Antigens. 2004 Jan;63(1):80-4.

PMID:
14651528
20.
21.

Use of a neural network to assign serologic specificities to HLA-A, -B and -DRB1 allelic products.

Maiers M, Schreuder GM, Lau M, Marsh SG, Fernandez-Viña M, Noreen H, Setterholm M, Katovich Hurley C.

Tissue Antigens. 2003 Jul;62(1):21-47.

PMID:
12859593
22.

HLAmatchmaker: a molecularly based algorithm for histocompatibility determination. III. Effect of matching at the HLA-A,B amino acid triplet level on kidney transplant survival.

Duquesnoy RJ, Takemoto S, de Lange P, Doxiadis II, Schreuder GM, Persijn GG, Claas FH.

Transplantation. 2003 Mar 27;75(6):884-9.

PMID:
12660519
23.

HLA class II is associated with distal interphalangeal osteoarthritis.

Riyazi N, Spee J, Huizinga TW, Schreuder GM, de Vries RR, Dekker FW, Kloppenburg M.

Ann Rheum Dis. 2003 Mar;62(3):227-30.

24.

Competition-based cellular peptide binding assays for 13 prevalent HLA class I alleles using fluorescein-labeled synthetic peptides.

Kessler JH, Mommaas B, Mutis T, Huijbers I, Vissers D, Benckhuijsen WE, Schreuder GM, Offringa R, Goulmy E, Melief CJ, van der Burg SH, Drijfhout JW.

Hum Immunol. 2003 Feb;64(2):245-55.

PMID:
12559627
25.

Histocompatibility and corneal transplantation.

Völker-Dieben HJ, Schreuder GM, Claas FH, Doxiadis II, Schipper RF, Pels E, Persijn GG, Smits J, D'Amaro J.

Dev Ophthalmol. 2003;36:22-41.

PMID:
12494678
26.

Nomenclature for factors of the HLA system, 2002.

Marsh SG, Albert ED, Bodmer WF, Bontrop RE, Dupont B, Erlich HA, Geraghty DE, Hansen JA, Mach B, Mayr WR, Parham P, Petersdorf E, Sasazuki T, Schreuder GM, Strominger JL, Svejgaard A, Terasaki PI.

Tissue Antigens. 2002 Nov;60(5):407-64. No abstract available.

PMID:
12492818
27.

Nomenclature for factors of the HLA system, 2002.

Marsh SG, Albert ED, Bodmer WF, Bontrop RE, Dupont B, Erlich HA, Geraghty DE, Hansen JA, Mach B, Mayr WR, Parham P, Petersdorf EW, Sasazuki T, Schreuder GM, Strominger JL, Svejgaard A, Terasaki PI.

Hum Immunol. 2002 Dec;63(12):1213-68. No abstract available.

PMID:
12480266
28.

HLA haplotypes and susceptibility to rheumatoid arthritis. More than class II genes.

Pascual M, Matarán L, Jones G, Shing D, van der Slik AR, Giphart MJ, Schreuder GM, de Vries RR, Breedveld FC, Roovers E, Zanelli E, Martin J.

Scand J Rheumatol. 2002;31(5):275-8.

PMID:
12455817
29.

Nomenclature for factors of the HLA system, 2002.

Marsh SG, Albert ED, Bodmer WF, Bontrop RE, Dupont B, Erlich HA, Geraghty DE, Hansen JA, Mach B, Mayr WR, Parham P, Petersdorf EW, Sasazuki T, Schreuder GM, Strominger JL, Svejgaard A, Terasaki PI.

Eur J Immunogenet. 2002 Dec;29(6):463-515. No abstract available.

PMID:
12437610
30.

Guidelines for nomenclature usage in HLA reports: ambiguities and conversion to serotypes.

Tiercy JM, Marsh SG, Schreuder GM, Albert E, Fischer G, Wassmuth R; European Federation for Immunogenetics subcommittee for reporting HLA ambiguities.

Eur J Immunogenet. 2002 Jun;29(3):273-4. No abstract available.

PMID:
12047366
31.

Sarcoid arthritis: clinical characteristics, diagnostic aspects, and risk factors.

Visser H, Vos K, Zanelli E, Verduyn W, Schreuder GM, Speyer I, Breedveld FC, Hazes JM.

Ann Rheum Dis. 2002 Jun;61(6):499-504.

32.

Early and aggressive treatment of rheumatoid arthritis patients affects the association of HLA class II antigens with progression of joint damage.

Lard LR, Boers M, Verhoeven A, Vos K, Visser H, Hazes JM, Zwinderman AH, Schreuder GM, Breedveld FC, De Vries RR, van der Linden S, Zanelli E, Huizinga TW.

Arthritis Rheum. 2002 Apr;46(4):899-905.

PMID:
11953965
33.

Influence of HLA polymorphism on persistent remission in rheumatoid arthritis.

Molenaar ET, Voskuyl AE, van der Horst-Bruinsma IE, Schreuder GM, Zanelli E, Dijkmans BA.

Ann Rheum Dis. 2002 Apr;61(4):351-3.

34.

Loss or downregulation of HLA class I expression at the allelic level in acute leukemia is infrequent but functionally relevant, and can be restored by interferon.

Brouwer RE, van der Heiden P, Schreuder GM, Mulder A, Datema G, Anholts JD, Willemze R, Claas FH, Falkenburg JH.

Hum Immunol. 2002 Mar;63(3):200-10.

PMID:
11872238
35.

The HLA Dictionary 2001: a summary of HLA-A, -B, -C, -DRB1/3/4/5 and -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR and -DQ antigens.

Schreuder GM, Hurley CK, Marsh SG, Lau M, Maiers M, Kollman C, Noreen HJ.

Eur J Immunogenet. 2001 Dec;28(6):565-96.

PMID:
11843954
36.

Six microsatellite markers on the short arm of chromosome 6 in relation to HLA-DR3 and TNF-308A in systemic lupus erythematosus.

van der Linden MW, van der Slik AR, Zanelli E, Giphart MJ, Pieterman E, Schreuder GM, Westendorp RG, Huizinga TW.

Genes Immun. 2001 Nov;2(7):373-80.

37.

Human leukocyte antigen-DQ and DR polymorphisms predict rheumatoid arthritis outcome better than DR alone.

Vos K, Visser H, Schreuder GM, de Vries RR, Zwinderman AH, Breedveld FC, Hazes JM, Zanelli EH.

Hum Immunol. 2001 Nov;62(11):1217-25.

PMID:
11704283
38.

The HLA Dictionary 2001: a summary of HLA-A, -B, -C, -DRB1/3/4/5, -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR and -DQ antigens.

Schreuder GM, Hurley CK, Marsh SG, Lau M, Maiers M, Kollman C, Noreen HJ.

Tissue Antigens. 2001 Aug;58(2):109-40.

PMID:
11696227
39.

Three newly identified HLA-B alleles: B*5124, B*5306, B*5307 and confirmation of B*0809 and B*5606.

Anholts JD, Kemps-Mols B, Verduijn W, Oudshoorn M, Schreuder GM.

Tissue Antigens. 2001 Jul;58(1):38-41.

PMID:
11580855
40.

Characterisation of a new HLA-B allele, HLA-B*0724.

Middleton D, Curran MD, Anholts JD, Reilly ER, Schreuder GM.

Tissue Antigens. 2001 May;57(5):471-3. No abstract available.

PMID:
11556973
41.

The relevance of proficiency testing for laboratories involved in cadaveric organ transplantation and its consequences for graft survival.

Doxiadis II, Witvliet M, Verduyn W, de Lange P, Tanke J, Schreuder GM, Persijn GG, Claas FH.

Clin Transpl. 2000:99-103.

PMID:
11512364
42.

The HLA dictionary 2001: a summary of HLA-A, -B, -C, -DRB1/3/4/5, -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR, and -DQ antigens.

Schreuder GM, Hurley CK, Marsh SG, Lau M, Maiers M, Kollman C, Noreen HJ.

Hum Immunol. 2001 Aug;62(8):826-49.

PMID:
11476907
43.

HLA class I and II in Lambert-Eaton myasthenic syndrome without associated tumor.

Wirtz PW, Roep BO, Schreuder GM, van Doorn PA, van Engelen BG, Kuks JB, Twijnstra A, de Visser M, Visser LH, Wokke JH, Wintzen AR, Verschuuren JJ.

Hum Immunol. 2001 Aug;62(8):809-13.

PMID:
11476904
44.

Nomenclature for factors of the HLA system, 2000.

Marsh SG, Bodmer JG, Albert ED, Bodmer WF, Bontrop RE, Dupont B, Erlich HA, Hansen JA, MacH B, Mayr WR, Parham P, Petersdorf EW, Sasazuki T, Schreuder GM, Strominger JL, Svejgaard A, Terasaki PI.

Eur J Immunogenet. 2001 Jun;28(3):377-424. No abstract available.

PMID:
11422419
45.

Determination of the frequency of HLA antibody secreting B-lymphocytes in alloantigen sensitized individuals.

Mulder A, Kardol MJ, Kamp J, Uit Het Broek C, Schreuder GM, Doxiadis II, Claas FH.

Clin Exp Immunol. 2001 Apr;124(1):9-15.

46.

Nomenclature for factors of the HLA system, 2000.

Marsh SG, Bodmer JG, Albert ED, Bodmer WF, Bontrop RE, Dupont B, Erlich HA, Hansen JA, Mach B, Mayr WR, Parham P, Petersdorf EW, Sasazuki T, Schreuder GM, Strominger JL, Svejgaard A, Terasaki PI.

Hum Immunol. 2001 Apr;62(4):419-68. No abstract available.

PMID:
11295476
47.

An HLA-DRB1-derived peptide associated with protection against rheumatoid arthritis is naturally processed by human APCs.

Snijders A, Elferink DG, Geluk A, van Der Zanden AL, Vos K, Schreuder GM, Breedveld FC, de Vries RR, Zanelli EH.

J Immunol. 2001 Apr 15;166(8):4987-93.

48.

Nomenclature for factors of the HLA system, 2000.

Marsh SG, Bodmer JG, Albert ED, Bodmer WF, Bontrop RE, Dupont B, Erlich HA, Hansen JA, Mach B, Mayr WR, Parham P, Petersdorf EW, Sasazuki T, Schreuder GM, Strominger JL, Svejgaard A, Terasaki PI.

Tissue Antigens. 2001 Mar;57(3):236-83. No abstract available.

PMID:
11285132
49.

HLA class II associations with Type 1 diabetes mellitus: a multivariate approach.

Schipper RF, Koeleman BP, Bruining GJ, Schreuder GM, Verduijn W, De Vries RR, Roep BO.

Tissue Antigens. 2001 Feb;57(2):144-50.

PMID:
11260509
50.

Evidence for a protective role of the human leukocyte antigen class II region in early rheumatoid arthritis.

Vos K, van der Horst-Bruinsma IE, Hazes JM, Breedveld FC, le Cessie S, Schreuder GM, de Vries RR, Zanelli E.

Rheumatology (Oxford). 2001 Feb;40(2):133-9.

PMID:
11257148

Supplemental Content

Loading ...
Support Center